» Articles » PMID: 37996702

Adipose CDC1s Contribute to Obesity-associated Inflammation Through STING-dependent IL-12 Production

Overview
Journal Nat Metab
Publisher Springer Nature
Specialty Endocrinology
Date 2023 Nov 23
PMID 37996702
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is associated with chronic low-grade white adipose tissue (WAT) inflammation that can contribute to the development of insulin resistance in mammals. Previous studies have identified interleukin (IL)-12 as a critical upstream regulator of WAT inflammation and metabolic dysfunction during obesity. However, the cell types and mechanisms that initiate WAT IL-12 production remain unclear. Here we show that conventional type 1 dendritic cells (cDC1s) are the cellular source of WAT IL-12 during obesity through analysis of mouse and human WAT single-cell transcriptomic datasets, IL-12 reporter mice and IL-12p70 protein levels by enzyme-linked immunosorbent assay. We demonstrate that cDC1s contribute to obesity-associated inflammation by increasing group 1 innate lymphocyte interferon-γ production and inflammatory macrophage accumulation. Inducible depletion of cDC1s increased WAT insulin sensitivity and systemic glucose tolerance during diet-induced obesity. Mechanistically, endocytosis of apoptotic bodies containing self-DNA by WAT cDC1s drives stimulator of interferon genes (STING)-dependent IL-12 production. Together, these results suggest that WAT cDC1s act as critical regulators of adipose tissue inflammation and metabolic dysfunction during obesity.

Citing Articles

The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity.

Wang Y, Yang S, Zhang S, Yang Y, Li S, Zhang M Front Endocrinol (Lausanne). 2025; 16:1446049.

PMID: 39980852 PMC: 11839430. DOI: 10.3389/fendo.2025.1446049.


Maternal exercise prevents metabolic disorders in offspring mice through SERPINA3C.

Li Y, Li R, Zhu J, Chen M, Mu W, Luo H Nat Metab. 2025; 7(2):401-420.

PMID: 39891022 DOI: 10.1038/s42255-024-01213-6.


Evaluating the causal effects between Grave's disease and diabetes mellitus: a bidirectional Mendelian randomization study.

Zhang Y, Fu L Front Endocrinol (Lausanne). 2024; 15:1420499.

PMID: 39568808 PMC: 11576183. DOI: 10.3389/fendo.2024.1420499.


Circadian gene signatures in the progression of obesity based on machine learning and Mendelian randomization analysis.

Cheng Z, Liu B, Liu X Front Nutr. 2024; 11:1407265.

PMID: 39351493 PMC: 11439728. DOI: 10.3389/fnut.2024.1407265.


No time to die: Epigenetic regulation of natural killer cell survival.

Hermans L, OSullivan T Immunol Rev. 2024; 323(1):61-79.

PMID: 38426615 PMC: 11102341. DOI: 10.1111/imr.13314.

References
1.
Ward Z, Bleich S, Cradock A, Barrett J, Giles C, Flax C . Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. N Engl J Med. 2019; 381(25):2440-2450. DOI: 10.1056/NEJMsa1909301. View

2.
Khaodhiar L, McCowen K, Blackburn G . Obesity and its comorbid conditions. Clin Cornerstone. 2000; 2(3):17-31. DOI: 10.1016/s1098-3597(99)90002-9. View

3.
Guh D, Zhang W, Bansback N, Amarsi Z, Birmingham C, Anis A . The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009; 9:88. PMC: 2667420. DOI: 10.1186/1471-2458-9-88. View

4.
Kahn S, Hull R, Utzschneider K . Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121):840-6. DOI: 10.1038/nature05482. View

5.
Despres J, Lemieux I . Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121):881-7. DOI: 10.1038/nature05488. View